Search Results 41-50 of 8285 for TNF
... Tumor Necrosis Factor (anti-TNF) agents infliximab, adalimumab, and certolizumab. However, many CD and UC patients still ultimately require surgery despite ...
The NF-kappa B activation is also responsible for tumor necrosis factor-alpha (TNF-alpha) and tumor necrosis factor (TNF)-related apoptosis-inducing ligand ( ...
Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy - Mayo Clinic. Overview Tab Title ...
... tumor necrosis factor alpha (TNFa) and interleukin-2 (IL-2). These cytokines result in immunological danger signaling and multiple appealing T-cell effects ...
... tumor necrosis factor (TNF)-a agents) ≤2 weeks prior to registration, or anticipation of need for systemic immunosuppressive medication during the course ...
A maximum of approximately 80% of subjects with any prior anti-TNF agent use will be allowed in the study. At the end of the double blind period, subjects ...
The research team discovered that increased activity of the alternative NF-kB pathway results from suppression of TNF receptor-associated factor 2, or TRAF2.
... tumor necrosis factor (TNF-IR). Participants who enroll on the basis of refractory or intolerance to CS and/or IS may have been previously exposed to anti ...
... TNF-inhibitors. Correlate local levels of antigen with systemic levels measured in serum using matched patient tissue and blood sample, and correlate local ...
... Tumor Necrosis Factor (TNF) therapy. A Study of Measurable Ultrasound Imaging Biomarkers of Crohn's Disease Rochester, MN. The purpose of this study is to ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.